Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [23869]

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk

Turning the tables on chemotherapy resistance: LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer

Turning the tables on chemotherapy resistance: LIG1 loss exposes a therapeutic vulnerability in triple-negative...

Cancer survivors and providers differ in views on medical cannabis, study finds

Cancer survivors and providers differ in views on medical cannabis, study finds

A vaccine to prevent pancreatic cancer in high-risk individuals was safe and elicited durable immune responses

A vaccine to prevent pancreatic cancer in high-risk individuals was safe and elicited durable immune responses

Early inflammation signal drives oral cancer development, highlights path for immunoprevention

Early inflammation signal drives oral cancer development, highlights path for immunoprevention

Tiny molecules, big possibilities: Researchers explore a new way to slow lung cancer

Tiny molecules, big possibilities: Researchers explore a new way to slow lung cancer

Researchers identify immune cell that builds cancer-fighting hubs inside tumours

Researchers identify immune cell that builds cancer-fighting hubs inside tumours

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally...

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

Researchers developing next-generation cancer therapies by switching off cancer’s DNA repair machinery

Researchers developing next-generation cancer therapies by switching off cancer’s DNA repair machinery

More from ecancer